Abstract
THE biological activity of an organic compound represents the sum of several properties, including solubility, absorption, transport, plasma protein binding, metabolism and receptor binding. The degree of molecular flexibility may affect these properties in different ways. Our approach to the design of somatostatin analogues with reduced susceptibility to metabolic inactivation has been both to eliminate those amino acids which are not required for biological activity and to increase the rigidity of the molecule. We report here the preparation of conformationally constrained analogues of somatostatin (Fig. 1, IIa and III) which are highly active inhibitors of the release of insulin, glucagon and growth hormone in vivo. Analogue III (Fig. 1), which retains only four of the amino acids of the natural hormone (sequence 7–10), is relatively resistant to the action of trypsin in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Veber, D. F. et al. Proc. natn. Acad. Sci. U.S.A. 75, 2636–2640 (1979).
Sarantakis, D., McKinley, W. A., Jaunakais, I., Clark, D. & Grant, N. H. Clin. Endocr. 5, 275–278S (1976).
Rudinger, J. & Jost, K. Experientia 20, 570–571 (1964).
Jost, K. & Rudinger, J. Colln Czech, chem. Commun. Engl. Edn 32, 1229–1241 (1967).
Vale, W., Rivier, J., Ling, N. & Brown, M. Metabolism 27, Suppl. 1, 1391–1401 (1978).
Arison, B. H., Hirschmann, R. & Veber, D. F. Bioorg. Chem. 7, 447–451 (1978).
Rivier, J., Brown, M. & Vale, W. Biochem. biophys. Res. Commun. 65, 746–751 (1975).
Torchiana, M. L., Cook, P. G., Weise, S. R., Saperstein, R. & Veber, D. F. Archs int. Pharmac. Ther. 235, 170–176 (1978).
Schonbrunn, A. & Tashjian, A. H. Jr J. biol. Chem. 253, 6473–6483 (1978).
Craig, L. C., Hausmann, W. & Weisiger, J. R. J. Am. chem. Soc. 76, 2839 (1954).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
VEBER, D., HOLLY, F., NUTT, R. et al. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size. Nature 280, 512–514 (1979). https://doi.org/10.1038/280512a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/280512a0
This article is cited by
-
Chemoenzymatic tandem cyclization for the facile synthesis of bicyclic peptides
Communications Chemistry (2024)
-
Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids
Amino Acids (2019)
-
Synthesis and in vitro antitumor activity of new octapeptide analogs of somatostatin containing unnatural amino acids
Amino Acids (2015)
-
Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin
Journal of Endocrinological Investigation (2002)
-
Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro
British Journal of Pharmacology (1997)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.